Stock Quotes in this Article: BIOD, PTX, LPDX

MADISON, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

>>5 Stocks Poised to Pop on Bullish Earnings

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.

>>5 Rocket Stocks Worth Buying This Week

Pernix Therapeutics

Pernix Therapeutics (PTX) is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a variety of therapeutic areas. This stock is trading up 2.9% to $3.83 in recent trading.

Today's Range: $3.72-$4.05

52-Week Range: $2.93-$9.20

Volume: 77,000

Three-Month Average Volume: 73,544

>>5 Stocks Poised to Break Out

From a technical perspective, PTX is trending higher here right off of its 50-day moving average at $3.61 with above-average volume. This stock has started to flirt with a big breakout here, since shares of PTX have tested some previous overhead resistance at $4.03. At last check, PTX has hit an intraday high of $4.05 and volume is just starting to surpass its three-month average action of 73,544 shares.

Traders should now look for long-biased trades in PTX as long as it's trending above its 50-day at $3.61 or above some more near-term support at $3.40, and then once it sustains a move or close above $4.03 to $4.05 with volume that hits near or above 73,544 shares. If that breakout triggers soon, then PTX will set up to re-test or possibly take out its next major overhead resistance levels at $5 to $5.18. Any high-volume move above those levels will then put its 200-day moving average at $6.26 into range for shares of PTX.

Biodel

Biodel (BIOD) is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes. This stock is trading up 8.6% to $4.76 in recent trading.

Today's Range: $4.40-$4.78

52-Week Range: $2.13-$4.95

Volume: 550,000

Three-Month Average Volume: 166,070

>>5 Big Trades for a Ping-Pong Market

From a technical perspective, BIOD is soaring higher here right above some near-term support at $4.18 with above-average volume. This stock has been uptrending strong for the last two months and change, with shares pushing higher from its low of $2.48 to its recent high of $4.95. During that move, shares of BIOD have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of BIOD within range of triggering a major breakout trade, which will hit if BIOD manages to take out some near-term overhead resistance levels at $4.70 to its 52-week high at $4.95 with high volume.

Traders should now look for long-biased trades in BIOD as long as it's trending above some key near-term support levels at $4.18 to $4.02 and then once it sustains a move or close above those breakout levels with volume that hits near or above 166,070 shares. If that breakout triggers soon, then BIOD will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $6 to $7.

LipoScience

LipoScience (LPDX) is an in vitro diagnostic company  that develops and markets diagnostic tests based on nuclear magnetic resonance technology. This stock is trading up 3.9% to $6.92 in recent trading.

Today's Range: $6.57-$6.91

52-Week Range: $5.55-$11.84

Volume: 68,000

Three-Month Average Volume: 63,806

>>5 Stocks Under $10 Set to Soar

From a technical perspective, LPDX is ripping higher here right off some near-term support at $6.50 with above-average volume. This stock has been uptrending strong for the last month and change, with shares moving higher from its low of $5.55 to its recent high of $7.20. During that move, shares of LPDX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of LPDX within range of triggering a major breakout trade, which will hit if LPDX manages to take out some near-term overhead resistance at $7.20 to its 50-day moving average at $7.58 with high volume.

Traders should now look for long-biased trades in LPDX as long as it's trending above some key near-term support levels at $6.50 to $6.40 and then once it sustains a move or close above those breakout levels with volume that hits near or above 63,806 shares. If that breakout triggers soon, then LPDX will set up to re-test or possibly take out its next major overhead resistance levels at $9 to $10.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Madison, Wis.

RELATED LINKS:

>>5 Sin Stocks to Play Defense
>>3 Stocks With Ever-Increasing Dividends

>>5 Hated Earnings Stocks That Deserve Your Love

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Madison, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.